These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study. Gurbel PA, Bliden KP, Fort J, Zhang Y, Plachetka JR, Antonino M, Gesheff M, Tantry US. Clin Pharmacol Ther; 2011 Dec; 90(6):860-6. PubMed ID: 22048221 [Abstract] [Full Text] [Related]
3. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study. Miner PB, Fort JG, Zhang Y. Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061 [Abstract] [Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole. Offman E, Schobelock MJ, Brickl R, VanderMaelen CP, Ehrlich J, Eisert W. Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686 [Abstract] [Full Text] [Related]
8. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers. Funck-Brentano C, Szymezak J, Steichen O, Ducint D, Molimard M, Remones V, Azizi M, Gaussem P. Arch Cardiovasc Dis; 2013 Dec; 106(12):661-71. PubMed ID: 24246616 [Abstract] [Full Text] [Related]